首页> 外文学位 >Characterization of neutrophil bactericidal activity in three-dimensional fibrin gels.
【24h】

Characterization of neutrophil bactericidal activity in three-dimensional fibrin gels.

机译:三维纤维蛋白凝胶中嗜中性粒细胞杀菌活性的表征。

获取原文
获取原文并翻译 | 示例

摘要

I developed and validated experimentally a simple, reproducible, three-dimensional in vitro fibrin gel system that is useful for many different types of analyses of interactions of leukocytes with one another, with microbes, and with other types of cells (e.g. tumor cells). These gels can be formed within minutes in sizes ranging from 50 mu--1500 mu in thickness and 6--100 mul in volume by addition of thrombin to solutions containing fibrinogen at concentrations similar to those found in plasma or exudates (i.e. 1--3 mg/ml). These gels can be lysed within minutes with trypsin or plasmin, allowing >99% recovery of mammalian and/or bacterial cells embedded within them.; I have used these fibrin gels to identify the involvement of various components of plasma (i.e. IgG, the third and fifth components of complement and their cleavage products), chemoattractants (i.e. C5a, LTB4 and fMLP), neutrophil membrane receptors (e.g. beta2 integrins), and cytosolic components (e.g. granules) in killing of Staphylococcus epidermidis by neutrophils. These experiments show that, (1) opsonization of S. epidermidis with C3 is required for neutrophil to kill these bacteria efficiently in fibrin gels; (2) C5a formed by C5 convertases on the surfaces of S. epidermidis increases the efficiency of neutrophil bactericidal activity at neutrophil concentrations 4 x 107/ml in fibrin gels, but not in stirred suspension. Optimal neutrophil bactericidal activity requires each bacterium to release C5a from its surface, thereby creating a gradient of C5a that directs neutrophils toward it; (3) fMLP, at concentrations found in human colon, inhibits neutrophil migration, thereby reducing the efficiency of neutrophil bactericidal activity in fibrin gels; (4) neutrophil bacterial killing in fibrin gels requires activated ERK but not beta2 integrins.; I developed a generally applicable mathematical model for assessing neutrophil bactericidal efficiency in stirred suspensions and in tissue-like environments at neutrophil concentrations ranging from 105 to 10 7/ml, and at bacterial concentrations ranging from 103 to 108 colony forming units (CFU)/ml.; Using my mathematical model I identified a new parameter for assessing the minimal neutrophil concentration needed to control bacterial growth. I have termed this new parameter the critical neutrophil concentration (CNC). The CNC is the neutrophil concentration at which the rate of neutrophil bacterial killing is precisely equal to the rate of bacterial growth. Thus at the CNC, the bacterial concentration remains constant. (Abstract shortened by UMI.)
机译:我开发并通过实验验证了一种简单,可重现的三维体外纤维蛋白凝胶系统,该系统可用于白细胞相互之间,与微生物以及与其他类型的细胞(例如肿瘤细胞)相互作用的多种不同类型的分析。通过将凝血酶加入浓度与血浆或渗出液中浓度相似的血纤蛋白原的溶液中,可以在几分钟内形成厚度为50μ-1500μ厚,体积为6--100 mul的凝胶,这些凝胶的浓度3 mg / ml)。这些凝胶可以在几分钟内用胰蛋白酶或纤溶酶裂解,使嵌入其中的哺乳动物和/或细菌细胞回收率> 99%。我已经使用这些纤维蛋白凝胶来确定血浆的各种成分(例如IgG,补体的第三和第五成分及其裂解产物),趋化剂(例如C5a,LTB4和fMLP),嗜中性粒细胞膜受体(例如beta2整合素)的参与情况,以及中性粒细胞杀死表皮葡萄球菌的胞浆成分(例如颗粒)。这些实验表明,(1)中性粒细胞需要用C3对表皮葡萄球菌进行调理作用,以在纤维蛋白凝胶中有效杀死这些细菌。 (2)在纤维蛋白凝胶中,中性粒细胞浓度<4 x 107 / ml时,由表皮葡萄球菌表面上的C5转化酶形成的C5a提高中性粒细胞杀菌活性的效率,但在搅拌的悬浮液中则没有。最佳的嗜中性粒细胞杀菌活性要求每种细菌从其表面释放C5a,从而产生一个将嗜中性粒细胞引向其中的C5a梯度。 (3)在人类结肠中发现的浓度的fMLP抑制嗜中性粒细胞迁移,从而降低了纤维蛋白凝胶中嗜中性粒细胞杀菌活性的效率; (4)在纤维蛋白凝胶中杀死嗜中性白细胞的细菌需要活化的ERK,而不需要β2整联蛋白。我开发了一种普遍适用的数学模型,用于评估中性粒细胞浓度范围为105至10 7 / ml,细菌浓度范围为103至108集落形成单位(CFU)/ ml的搅拌悬浮液和组织样环境中的中性粒细胞杀菌效率。;使用我的数学模型,我确定了一个新参数,用于评估控制细菌生长所需的最低嗜中性粒细胞浓度。我将这个新参数称为临界中性粒细胞浓度(CNC)。 CNC是中性粒细胞浓度,在该浓度时中性粒细胞细菌杀灭率正好等于细菌生长速率。因此,在CNC,细菌浓度保持恒定。 (摘要由UMI缩短。)

著录项

  • 作者

    Li, Yongmei.;

  • 作者单位

    Columbia University.;

  • 授予单位 Columbia University.;
  • 学科 Health Sciences Immunology.; Health Sciences Pharmacology.
  • 学位 Ph.D.
  • 年度 2003
  • 页码 227 p.
  • 总页数 227
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 预防医学、卫生学;药理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号